IDEXX Laboratories Announces First Quart...(Three Months Ended ...),Health

Date:4/24/2009

Three Months Ended Per- centage Change Net of Per- Acq- centage uisi- Change tions/ from Divesti- Per- Acq- tures centage uisi- and Change tions/ Curr- Per- from Divesti- ency Net CAG Mar. 31, Mar. 31, Dollar centage Currency tures Effect Revenue 2009 2008 Change Change (1) (2) (3) Instruments and consumables $72,235 $75,610 $(3,375) (4.5%) (7.3%) - 2.8% Rapid assay products 37,677 38,711 (1,034) (2.7%) (1.7%) - (1.0%) Laboratory and consulting services 68,692 70,107 (1,415) (2.0%) (7.8%) - 5.8% Practice information management systems and digital radiography 15,034 15,025 9 0.1% (3.0%) - 3.1% Pharmaceutical products 54 3,338 (3,284) (98.4%) - (100.0%) 1.6% Net CAG revenue $193,692 $202,791 $(9,099) (4.5%) (6.0%) (1.6%) 3.1% (1) Represents the percentage change in revenue attributed to the effect of changes in currency rates fr
'/>"/>

SOURCE IDEXX Laboratories, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related medicine news :

1. IDEXX Laboratories to Present at JPMorgan Healthcare Conference
2. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
3. IDEXX Laboratories Announces Fourth Quarter Results
4. IDEXX Laboratories Announces Increase in Share Repurchase Program
5. IDEXX Laboratories to Release 2008 First Quarter Financial Results
6. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
7. IDEXX Laboratories Names William Brown Corporate Vice President
8. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
9. IDEXX Laboratories Announces Fourth Quarter and Full Year Results
10. IDEXX Laboratories to Release 2009 First Quarter Financial Results
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)